Chinese business elite tour Westmead Health Precinct

Chinese and Australian health industry leaders gathered at the Westmead Institute of Medical Research to discuss investment opportunities.

Health industry leaders have gone behind the scenes at Westmead Health Precinct as they celebrate a 40-year relationship between NSW and China.

The 27th biennial NSW-Guangdong Joint Economic Meeting brought together 100 senior business leaders from NSW for a landmark event with visiting business leaders from the southern Chinese province Guangdong.

The meeting targeted four industry-focused streams including health, medical and life sciences technology, which brought the delegates to Westmead Health Precinct to highlight the capabilities and strengths of NSW at the beating heart of health research and innovation.

WSLHD chief executive Graeme Loy.

Western Sydney Local Health District (WSLHD) chief executive Graeme Loy said Westmead is a great place to invest in healthcare.

“Western Sydney has a large and diverse population, an excellent clinical and research workforce, and strong clinical networks and trials infrastructure,” Graeme said.

“There was great interest from the Guangdong representatives in the world-class research ecosystem emerging here.”

Graeme said the new $1.1 billion redevelopment is a perfect example of the investment in Westmead and the cooperation between government, research and education institutions.

About 30 delegates including health industry representatives from NSW and Guangdong gathered at the Westmead Institute for Medical Research to showcase the Westmead Health Precinct, which includes four major hospitals, three world-leading medical research institutes and the state’s largest research-intensive pathology service.

The ongoing relationship will open more opportunities for Guangdong-based companies to potentially become involved trials in Westmead, and for NSW-based healthcare providers to do business in Guangdong.